1. Calhoun DA, Booth JN, 3rd, Oparil S, Irvin MR, Shimbo D, Lackland DT, et al. Refractory hyper-tension: determination of prevalence, risk factors, and comorbidities in a large, population-based cohort. Hypertension. 2014;63(3):451-8
2. Judd E, Calhoun DA. Apparent and true resistant hypertension: definition, prevalence and outcomes. Journal of human hypertension. 2014;28(8):463-8.
3. Achelrod D, Wenzel U, Frey S. Systematic review and meta-analysis of the prevalence of resistant hypertension in treated hypertensive populations. American journal of hypertension. 2015;28(3):355-6
4. Brambilla G, Bombelli M, Seravalle G, Cifkova R, Laurent S, Narkiewicz K, et al. Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study. Journal of hypertension. 2013;31(10):2018-24.
5. Prejbisz A, Klocek M, Gasowski J, Topor-Madry R, Lesniak W, Kabat M, et al. Factors associated with resistant hypertension in a large cohort of hypertensive patients: the Pol-Fokus study. Polskie Archiwum Medycyny Wewnetrznej. 2015; 125(4): 249-59.
6. Hung CY, Wang KY, Wu TJ, Hsieh YC, Huang JL, Loh el W, et al. Resistant hypertension, patient characteristics, and risk of stroke. PloS one. 2014;9(8):e104362.